SOD1 and bladder transitional cell carcinoma: It has been reported that the expression of CEBPD reduced cisplatin-induced ROS and apoptosis in bladder urothelial carcinoma cells by inducing Cu/Zn-superoxide dismutase (SOD1) [20].